Reagent needed for the critical care medicine department for research.

Ended Awarded Last action

Contract number
75N90025F00001
Awardee
Awarding agency
Obligated
$13,774

Award facts

Contract value 100% obligated
$13,774.25 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The NIH Clinical Center issued a BPA call to 10X Genomics, Inc. valued at $13,774.25 on December 31, 2024, for reagent supply to the Critical Care Medicine Department for research purposes. The call is firm fixed price with an ultimate completion date of January 30, 2025. Place of performance is Pleasanton, California. No set-aside applied to this call.

Quick answers

Who was awarded contract 75N90025F00001?

75N90025F00001 was awarded to 10X Genomics, Inc. by NIH Clinical Center (National Institutes of Health) on December 31, 2024.

How much is contract 75N90025F00001 worth?

The government has obligated $13,774 on 75N90025F00001.

Is contract 75N90025F00001 an order under another contract?

Yes. 75N90025F00001 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N90025F00001 competed?

The extent of competition for 75N90025F00001 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award